Health

asad ullah Jan 13, 2024, 7:06 AM
A Couple of Pizza Thieves Were Caught Red Handed by Bo, a 10-Month-Old Bloodhound, Who Just Joined the Police Force
Read More
admin Nov 1, 2023, 10:06 AM
LAHORE: The Punjab government has decided to ‘lift’ the ban on the use of Avastin injection, which allegedly caused blurry...
Read More
admin Nov 1, 2023, 10:04 AM
Belgium’s drug regulator said it had seized counterfeit versions of semaglutide, the active ingredient in Novo Nordisk’s popular obesity drug...
Read More
admin Nov 1, 2023, 10:02 AM
ISLAMABAD: Caretaker Federal Minister for Health Dr Nadeem Jan on Monday said that the recruitment of heads of major hospitals...
Read More
admin Nov 1, 2023, 10:00 AM
Lahore ranked top of the list of the most polluted cities in the world today having the worst air quality,...
Read More
admin Nov 1, 2023, 9:58 AM
Eli Lilly and Co said on Thursday that the U.S. health regulator had approved Omvoh, its drug for treating adults with moderate-to-severe active ulcerative colitis, a type of chronic inflammatory bowel disease. The drug, which will be available in the United States in coming weeks and sold under brand name Omvoh, is among Lilly’s potential growth drivers for this decade alongside tirzepatide for obesity, lebrikizumab for atopic dermatitis or eczema and pirtobrutinib for cancer. The agency’s decision will help Lilly enter a sector, where drugs from rivals such as Abbvie, Pfizer and Johnson & Johnson are already jostling for a share of the multi-billion dollar market.
Read More